FDA
The latest news on FDA
But ruling from another court could still delay or thwart use of graphic anti-smoking images
Latest formulation is tougher to crush and dissolve, making illicit use more difficult
Dangerous stimulant DMAA is sold under variety of ingredient names, agency says
Many U.S., Canadian and French physicians prescribed the promoted meds anyway
Among pregnant women who haven't responded to other treatments
Safety issues resolved, experts say Diclegis' return is long overdue
Until now, girls 16 and younger needed a prescription for the emergency contraception
The “morning after pill” must be made available to people of all ages without restriction, federal judge says.
Little danger of addiction or abuse seen after years on the market
Invokana blocks reabsorption of glucose by the kidneys
